Cardiovascular system

Adenosine monophosphate has an equivalent in the molecule known as AICAR. In clinical studies, it has been found to reduce the risk of cardiac ischemia occurring after a prior heart attack. Due to its antioxidant characteristics, AICAR may aid in reducing the physiologic effects of ageing. The use of AICAR reduce the consequences of diabetes, autoimmune illnesses, and other inflammatory conditions.

Adenosine monophosphate has an equivalent in the molecule known as AICAR. In clinical studies, it has been found to reduce the risk of cardiac ischemia occurring after a prior heart attack. Due to its antioxidant characteristics, AICAR may aid in reducing the physiologic effects of ageing. The use of AICAR reduce the consequences of diabetes, autoimmune illnesses, and other inflammatory conditions. Total Spray: 82 (1,22 mg per spray)FRESHLY PREPARED SOLUTION

It has been shown that the erythropoietin variation known as ARA-290 may reduce the activity of inflammatory pathways by using paracrine signalling and the innate repair receptors. According to research, ARA-290 may help lower HbA1c levels, improve cholesterol, modify peripheral neuropathies and general neuropathic pain, promote wound regeneration, and alleviate general neuropathic pain. - Cardiovascular disorders - Diabetic macular edema - Diabetic neuropathies - Neuropathic pain - Small fiber neuropathy - Rheumatoid arthritis - Diabetic nephropathies - Non-alcoholic steatohepatitis - Inflammatory bowel diseases - Systemic lupus erythematosus - Wounds   Total Spray: 82 (490 mcg per spray)FRESHLY PREPARED SOLUTION

It has been shown that the erythropoietin variation known as ARA-290 may reduce the activity of inflammatory pathways by using paracrine signalling and the innate repair receptors. According to research, ARA-290 may help lower HbA1c levels, improve cholesterol, modify peripheral neuropathies and general neuropathic pain, promote wound regeneration, and alleviate general neuropathic pain. - Cardiovascular disorders - Diabetic macular edema - Diabetic neuropathies - Neuropathic pain - Small fiber neuropathy - Rheumatoid arthritis - Diabetic nephropathies - Non-alcoholic steatohepatitis - Inflammatory bowel diseases - Systemic lupus erythematosus - Wounds

B7-33 exhibits a powerful anti-fibrotic effect. It has been shown that it may minimize the production of excessive scar tissue after heart damage. Additionally, it has shown potential in the treatment of certain vascular problems as well as the preeclampsia that may occur during pregnancy. - Anti-Fibrotic Properties - Blood Vessel Protection - Acute heart failure - Lung inflammation

B7-33 exhibits a powerful anti-fibrotic effect. It has been shown that it may minimize the production of excessive scar tissue after heart damage. Additionally, it has shown potential in the treatment of certain vascular problems as well as the preeclampsia that may occur during pregnancy. - Anti-Fibrotic Properties - Blood Vessel Protection - Acute heart failure - Lung inflammation   Total Spray: 82 (244 mcg per spray)FRESHLY PREPARED SOLUTION

BPC-157 is a penta-decapeptide comprised of 15 amino acids. It has been shown to have effects on: - Fast recovery from muscle tears - Wound healing - Ligament healing - Healing and prevention of gastric ulcers and inflammatory bowel diseases - Blood vessel growth - The coagulation cascade - Nitric oxide generation - Immune system function - Gene expression Hormone regulationThymosin Beta-4 is a 43 amino acid peptide sequence. Recent research and clinical trials done utilizing TB-500 (Thymosin Beta 4) have established that it has a variety of advantages, including the following: - Improves blood vessel growth - Controls wound healing - Reduces inflammation - Minimises oxidative injury to the heart and central nervous system - Additionally, it aids in tissue regeneration, remodeling, and protection of wounded or damaged tissues.

BPC-157 is a penta-decapeptide comprised of 15 amino acids. It has been shown to have effects on: - Fast recovery from muscle tears - Wound healing - Ligament healing - Healing and prevention of gastric ulcers and inflammatory bowel diseases - Blood vessel growth - The coagulation cascade - Nitric oxide generation - Immune system function - Gene expression Hormone regulationThymosin Beta-4 is a 43 amino acid peptide sequence. Recent research and clinical trials done utilizing TB-500 (Thymosin Beta 4) have established that it has a variety of advantages, including the following: - Improves blood vessel growth - Controls wound healing - Reduces inflammation - Minimises oxidative injury to the heart and central nervous system Additionally, it aids in tissue regeneration, remodeling, and protection of wounded or damaged tissues.Total Spray: 82 (BPC-157 365 mcg + TB-500 182 mcg per spray) FRESHLY PREPARED SOLUTION

The short peptide known as Cardiogen has been shown to possess bioregulator-like qualities. According to research, the major impacts that it has are on fibroblasts, which are the cells that are essential for tissue healing and scar formation all across the body.   Total Spray: 82 (609 mcg per spray)FRESHLY PREPARED SOLUTION

The short peptide known as Cardiogen has been shown to possess bioregulator-like qualities. According to research, the major impacts that it has are on fibroblasts, which are the cells that are essential for tissue healing and scar formation all across the body.

Chonluten is a peptide that regulates gene expression and is short in length. According to research, it is primarily active in the tissue of the lungs, with only secondary levels of activity being found in the GI tract. Chonluten's ability to regulate pulmonary mucosal function could be particularly useful in the treatment of chronic inflammatory lung illnesses including asthma, COPD, and in acute and chronic respiratory disorders of infectious and non-infectious origin, as well as for preserving the function of the respiratory system in older patients. Chonluten has been shown to have effects on: - After pneumonia - Chronic cardiopulmonary insufficiency - Chronic respiratory failure - After prolonged artificial ventilation - Pulmonary tuberculosis in remission - In case of respiratory distress syndrome - Intense sports - To maintain the function of the respiratory system in elderly - Asthma - Crohn’s disease and Ulcerative Colitis.   Total Spray: 82 (609 mcg per spray)FRESHLY PREPARED SOLUTION

Chonluten is a peptide that regulates gene expression and is short in length. According to research, it is primarily active in the tissue of the lungs, with only secondary levels of activity being found in the GI tract. Chonluten's ability to regulate pulmonary mucosal function could be particularly useful in the treatment of chronic inflammatory lung illnesses including asthma, COPD, and in acute and chronic respiratory disorders of infectious and non-infectious origin, as well as for preserving the function of the respiratory system in older patients. Chonluten has been shown to have effects on: - After pneumonia - Chronic cardiopulmonary insufficiency - Chronic respiratory failure - After prolonged artificial ventilation - Pulmonary tuberculosis in remission - In case of respiratory distress syndrome - Intense sports - To maintain the function of the respiratory system in elderly - Asthma - Crohn’s disease and Ulcerative Colitis.